Literature DB >> 2551434

Hemorrhagic cystitis associated with urinary excretion of adenovirus type 11 following allogeneic bone marrow transplantation.

K Miyamura1, K Takeyama, S Kojima, S Minami, K Matsuyama, Y Morishima, Y Kodera.   

Abstract

We studied a total of 50 recipients who had received allogeneic bone marrow transplantation (BMT) and evaluated both the presence of hemorrhagic cystitis (HC) and the urinary excretion of adenovirus. Twelve recipients developed HC and eight of these 12 patients excreted adenovirus type 11 at the onset of cystitis. Urine for virus isolation was attempted 30, 60 and 100 days after BMT. Among 137 specimens examined, eight were positive for adenovirus type 11. Of these eight samples, six were collected during HC; while in the 129 samples which were negative for adenovirus, only three specimens was collected during HC. Female patients, seropositivity for the antibody to adenovirus prior to BMT and acute graft-versus-host disease (grade 2-4) showed a significant impact on the risk of adenovirus HC. It may be said that adenovirus type 11 is one of the causative agents of HC in BMT recipients.

Entities:  

Mesh:

Year:  1989        PMID: 2551434

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  10 in total

Review 1.  Prevention of viral infections after bone marrow transplantation.

Authors:  U Schuler; G Ehninger
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

Review 2.  Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation.

Authors:  M T LaRocco; S J Burgert
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

3.  Hemorrhagic cystitis in adults after unrelated cord blood transplantation: a single-institution experience in Japan.

Authors:  Akira Tomonari; Satoshi Takahashi; Jun Ooi; Kenji Fukuno; Kashiya Takasugi; Nobuhiro Tsukada; Takaaki Konuma; Nobuhiro Ohno; Kaoru Uchimaru; Tohru Iseki; Arinobu Tojo; Shigetaka Asano
Journal:  Int J Hematol       Date:  2006-10       Impact factor: 2.490

Review 4.  Renal function following hematological stem cell transplantation in childhood.

Authors:  Ludwig Patzer; Karim Kentouche; Felix Ringelmann; Joachim Misselwitz
Journal:  Pediatr Nephrol       Date:  2003-04-29       Impact factor: 3.714

5.  Extensive cross-reactivity of CD4+ adenovirus-specific T cells: implications for immunotherapy and gene therapy.

Authors:  Bianca Heemskerk; Louise A Veltrop-Duits; Tamara van Vreeswijk; Monique M ten Dam; Sebastiaan Heidt; Rene E M Toes; Maarten J D van Tol; Marco W Schilham
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

Review 6.  Viral lower urinary tract infections.

Authors:  Darius A Paduch
Journal:  Curr Urol Rep       Date:  2007-07       Impact factor: 3.092

Review 7.  Post-transplantation cyclophosphamide to facilitate HLA-haploidentical hematopoietic cell transplantation: Mechanisms and results.

Authors:  Hany Elmariah; Ephraim J Fuchs
Journal:  Semin Hematol       Date:  2018-09-20       Impact factor: 3.754

8.  Conjugated Estrogen in Late-Onset Hemorrhagic Cystitis Associated with Hematopoietic Stem Cell Transplantation.

Authors:  Seyed Asadollah Mousavi; Vahid Moazed; Niayesh Mohebbi; Molouk Hadjibabaie; Kamran Alimoghaddam; Babak Bahar; Mohammad Jahani; Ardeshir Ghavamzadeh
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-01-01

9.  Isolation of a novel intertypic recombinant human mastadenovirus B2 from two unrelated bone marrow transplant recipients.

Authors:  A E Kajon; D M Lamson; E Spiridakis; A M Cardenas; N E Babady; B T Fisher; K St George
Journal:  New Microbes New Infect       Date:  2020-04-09

10.  Effectiveness of hyperbaric oxygen therapy for virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation.

Authors:  Kohei Hosokawa; Go Aoki; Kinya Ohata; Hiroyuki Takamatsu; Noriharu Nakagawa; Tatsuya Imi; Noriko Iwaki; Kiyoaki Ito; Mitsuhiro Kawano; Takashi Nakamura; Masato Takamori; Ken Ishiyama; Yukio Kondo; Hirohito Yamazaki; Shinji Nakao
Journal:  Int J Hematol       Date:  2021-03-16       Impact factor: 2.490

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.